Anke Smits1, Alberto Lopes1, Nagindra Das1, Ruud Bekkers2, Leon Massuger2, Khadra Galaal3. 1. Gynaecological Oncology, Royal Cornwall Hospital Trust, Truro, United Kingdom. 2. Obstetrics & Gynaecology, Radboud UMC, Nijmegen, The Netherlands. 3. Gynaecological Oncology, Royal Cornwall Hospital Trust, Truro, United Kingdom. Electronic address: khadra.galaal@rcht.cornwall.nhs.uk.
Abstract
OBJECTIVE: We aimed to evaluate the effectiveness of lifestyle interventions in improving the quality of life (QoL) of endometrial and ovarian cancer survivors. METHODS: The review was performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, and the Cochrane Handbook for Systematic Reviews of Interventions. We performed a search of MEDLINE (1946-2015), EMBASE (1980-2015), CINAHL (1981-2015), PsycINFO (1806-2015) and the Cochrane Trial Register to identify studies evaluating the effect of lifestyle interventions on the QoL of endometrial and ovarian cancer survivors. RESULTS: Eight studies fulfilled the inclusion criteria and comprised a total of 413 patients. Three studies were randomised controlled trials (RCTs), which showed that lifestyle interventions may improve physical functioning and significantly reduce fatigue in endometrial cancer survivors. In addition, lifestyle interventions in endometrial cancer survivors resulted in significant weight loss and improved physical activity levels, but did not show improvements in global QoL in the meta-analysis (P=0.75, P=0.49). Non-randomised trials in ovarian cancer survivors support the feasibility of lifestyle interventions and suggest they may result in QoL improvements. CONCLUSIONS: Lifestyle interventions have the potential to improve the QoL of endometrial cancer and ovarian cancer survivors, and may significantly reduce fatigue. However, the current evidence is limited and there is a need for future studies to further evaluate lifestyle interventions and their effect on QoL outcomes.
OBJECTIVE: We aimed to evaluate the effectiveness of lifestyle interventions in improving the quality of life (QoL) of endometrial and ovarian cancer survivors. METHODS: The review was performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, and the Cochrane Handbook for Systematic Reviews of Interventions. We performed a search of MEDLINE (1946-2015), EMBASE (1980-2015), CINAHL (1981-2015), PsycINFO (1806-2015) and the Cochrane Trial Register to identify studies evaluating the effect of lifestyle interventions on the QoL of endometrial and ovarian cancer survivors. RESULTS: Eight studies fulfilled the inclusion criteria and comprised a total of 413 patients. Three studies were randomised controlled trials (RCTs), which showed that lifestyle interventions may improve physical functioning and significantly reduce fatigue in endometrial cancer survivors. In addition, lifestyle interventions in endometrial cancer survivors resulted in significant weight loss and improved physical activity levels, but did not show improvements in global QoL in the meta-analysis (P=0.75, P=0.49). Non-randomised trials in ovarian cancer survivors support the feasibility of lifestyle interventions and suggest they may result in QoL improvements. CONCLUSIONS: Lifestyle interventions have the potential to improve the QoL of endometrial cancer and ovarian cancer survivors, and may significantly reduce fatigue. However, the current evidence is limited and there is a need for future studies to further evaluate lifestyle interventions and their effect on QoL outcomes.
Authors: Maria Gabriella Giganti; Ilaria Tresoldi; Roberto Sorge; Giovanni Melchiorri; Tamara Triossi; Laura Masuelli; Paolo Lido; Loredana Albonici; Calogero Foti; Andrea Modesti; Roberto Bei Journal: Oncol Lett Date: 2016-07-20 Impact factor: 2.967
Authors: Nora L Nock; Anastasia Dimitropoulos; Kristine M Zanotti; Steven Waggoner; Christa Nagel; Mladen Golubic; Chad M Michener; John P Kirwan; Jay Alberts Journal: Support Care Cancer Date: 2019-09-02 Impact factor: 3.603
Authors: Chun-Pin Chang; Yuji Chen; Brenna Blackburn; Sarah Abdelaziz; Kerry Rowe; John Snyder; Mark Dodson; Vikrant Deshmukh; Michael Newman; Joseph B Stanford; Christina A Porucznik; Jennifer Ose; Alison Fraser; Ken Smith; Jennifer Doherty; David Gaffney; Mia Hashibe Journal: Gynecol Oncol Date: 2020-02-29 Impact factor: 5.482
Authors: Andrew Gallagher; Violetta Shersher; Duncan Mortimer; Helen Truby; Terry Haines Journal: Appl Health Econ Health Policy Date: 2022-09-27 Impact factor: 3.686
Authors: Shannon D Armbruster; Jaejoon Song; Andrea Bradford; Cindy L Carmack; Karen H Lu; Karen M Basen-Engquist Journal: Gynecol Oncol Date: 2016-09-24 Impact factor: 5.482
Authors: Mackenzi Pergolotti; Antoine Bailliard; Lauren McCarthy; Erica Farley; Kelley R Covington; Kemi M Doll Journal: Am J Occup Ther Date: 2020 May/Jun
Authors: Sarah Kitson; Neil Ryan; Michelle L MacKintosh; Richard Edmondson; James Mn Duffy; Emma J Crosbie Journal: Cochrane Database Syst Rev Date: 2018-02-01